Annual EBITDA
-$55.43 M
-$20.20 M-57.34%
31 December 2023
Summary:
CG Oncology Common stock annual earnings before interest, taxes, depreciation & amortization is currently -$55.43 million, with the most recent change of -$20.20 million (-57.34%) on 31 December 2023. CGON annual EBITDA is now -347.83% below its all-time high of -$12.38 million, reached on 01 December 2021.CGON EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$28.27 M
-$2.43 M-9.39%
30 September 2024
Summary:
CG Oncology Common stock quarterly earnings before interest, taxes, depreciation & amortization is currently -$28.27 million, with the most recent change of -$2.43 million (-9.39%) on 30 September 2024. Over the past year, it has dropped by -$14.24 million (-101.41%). CGON quarterly EBITDA is now -203.66% below its all-time high of -$9.31 million, reached on 01 December 2022.CGON Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$95.94 M
-$14.24 M-17.42%
30 September 2024
Summary:
CG Oncology Common stock TTM earnings before interest, taxes, depreciation & amortization is currently -$95.94 million, with the most recent change of -$14.24 million (-17.42%) on 30 September 2024. Over the past year, it has dropped by -$50.55 million (-111.37%). CGON TTM EBITDA is now -930.35% below its all-time high of -$9.31 million, reached on 01 December 2022.CGON TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CGON EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -57.3% | -101.4% | -111.4% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
CGON EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -347.8% | at low | -203.7% | at low | -930.4% | at low |
| 5 y | 5 years | -347.8% | at low | -203.7% | at low | -930.4% | at low |
| alltime | all time | -347.8% | at low | -203.7% | at low | -930.4% | at low |
CG Oncology Common Stock EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$28.27 M(+9.4%) | -$95.94 M(+17.4%) |
| June 2024 | - | -$25.85 M(+15.1%) | -$81.70 M(+19.8%) |
| Mar 2024 | - | -$22.46 M(+16.1%) | -$68.18 M(+23.0%) |
| Dec 2023 | -$55.43 M | -$19.35 M(+37.8%) | -$55.43 M(+22.1%) |
| Sept 2023 | - | -$14.04 M(+13.9%) | -$45.39 M(+44.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$12.32 M(+26.8%) | -$31.35 M(+64.8%) |
| Mar 2023 | - | -$9.72 M(+4.4%) | -$19.03 M(+104.4%) |
| Dec 2022 | -$35.23 M(+184.6%) | - | - |
| Dec 2022 | - | -$9.31 M | -$9.31 M |
| Dec 2021 | -$12.38 M | - | - |
FAQ
- What is CG Oncology Common stock annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for CG Oncology Common stock?
- What is CG Oncology Common stock annual EBITDA year-on-year change?
- What is CG Oncology Common stock quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for CG Oncology Common stock?
- What is CG Oncology Common stock quarterly EBITDA year-on-year change?
- What is CG Oncology Common stock TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for CG Oncology Common stock?
- What is CG Oncology Common stock TTM EBITDA year-on-year change?
What is CG Oncology Common stock annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of CGON is -$55.43 M
What is the all time high annual EBITDA for CG Oncology Common stock?
CG Oncology Common stock all-time high annual earnings before interest, taxes, depreciation & amortization is -$12.38 M
What is CG Oncology Common stock annual EBITDA year-on-year change?
Over the past year, CGON annual earnings before interest, taxes, depreciation & amortization has changed by -$20.20 M (-57.34%)
What is CG Oncology Common stock quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of CGON is -$28.27 M
What is the all time high quarterly EBITDA for CG Oncology Common stock?
CG Oncology Common stock all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$9.31 M
What is CG Oncology Common stock quarterly EBITDA year-on-year change?
Over the past year, CGON quarterly earnings before interest, taxes, depreciation & amortization has changed by -$14.24 M (-101.41%)
What is CG Oncology Common stock TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of CGON is -$95.94 M
What is the all time high TTM EBITDA for CG Oncology Common stock?
CG Oncology Common stock all-time high TTM earnings before interest, taxes, depreciation & amortization is -$9.31 M
What is CG Oncology Common stock TTM EBITDA year-on-year change?
Over the past year, CGON TTM earnings before interest, taxes, depreciation & amortization has changed by -$50.55 M (-111.37%)